Muller & Phipps (India) Limited (MULLER.BO) markets and distributes over-the-counter medical preparations and home care products throughout India; its core offerings include Cavisan Medicated Dental Cream, Cavifast Medicated Dental Gel, Cavisan Gum Astringent, and Nixoderm skin care products, with additional consumer and OTC pharmaceutical items marketed via an extensive distribution network covering approximately 40,100 chemists, 65,700 general stores, 82,450 provisional and kirana stores, and 2,345 supermarkets across major cities such as Mumbai, Delhi, Chennai, Kolkata, Bangalore, Hyderabad, and others. Founded in 1917 and headquartered at 204 Madhava Commercial Premises, C-4 Bandra Kurla Complex, Bandra East, Mumbai, the company operates as a trading entity with state-level sales offices led by dedicated managers, providing warehousing, despatching, and brand marketing services to principals in the consumer products and pharma segments. In recent developments, the company reported unaudited financial results for the quarter ended June 30, 2025, approved its Annual General Meeting for September 23, 2025, and made appointments to its board of directors and company secretary roles, while its affiliated Middle East group pursued strategic expansions including the acquisition of Power League Gaming assets in 2024 to bolster technology distribution and esports capabilities in the MENA region.